Jagsonpal Pharmaceuticals Limited (BOM: 507789)

Jagsonpal Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	778.45	127.6	110.53	225.26	589.43	398.13
Short-Term Investments	-	1,352	1,036	245.31	-	-
Trading Asset Securities	-	-	-	-	32.51	-
Cash & Short-Term Investments	778.45	1,479	1,146	470.57	621.94	398.13
Cash Growth	-30.24%	29.06%	143.59%	-24.34%	56.21%	3.32%
Accounts Receivable	194.86	109.51	208.72	155.77	126.64	214.53
Other Receivables	-	-	-	-	15.37	10.33
Receivables	194.86	109.51	208.72	155.77	142.01	228.15
Inventory	167.98	149.97	206.76	297.42	297.25	293.25
Prepaid Expenses	-	13.59	10.68	10.62	-	-
Other Current Assets	246.57	240.13	73.17	156.43	143.58	43.53
Total Current Assets	1,388	1,993	1,646	1,091	1,205	963.07
Property, Plant & Equipment	99.96	93.02	242.78	225.73	233.47	239.64
Long-Term Investments	161.63	47	33.84	290.55	120.58	113.87
Goodwill	96.93	-	-	0.3	0.3	0.3
Long-Term Deferred Charges	-	-	-	-	23.45	23.45
Other Long-Term Assets	38.08	38.22	27.25	34.86	59.45	141.44
Total Assets	2,582	2,171	1,949	1,642	1,642	1,487
Accounts Payable	141.21	75.96	165.8	185.5	180.5	117.09
Accrued Expenses	6.32	81.71	88.86	79.86	89.37	66.65
Short-Term Debt	-	-	-	-	67.88	64.04
Current Portion of Leases	16.16	13.84	7.54	-	-	-
Current Income Taxes Payable	4.51	-	0.19	2.33	38.22	83
Current Unearned Revenue	-	12.94	6.12	-	-	-
Other Current Liabilities	301.71	6.83	7.2	2.03	28	14.9
Total Current Liabilities	469.91	191.28	275.71	269.72	403.97	345.68
Long-Term Leases	81.98	75.57	52.47	-	-	-
Long-Term Deferred Tax Liabilities	36.43	20.73	21.63	32.38	18.59	30.92
Other Long-Term Liabilities	22.63	9.18	10.75	12.56	-	-
Total Liabilities	610.95	296.76	360.56	314.66	422.73	376.6
Common Stock	132.42	132.19	130.99	130.99	130.99	130.99
Additional Paid-In Capital	-	111.2	6	6	6	6
Retained Earnings	-	1,460	1,363	1,112	1,004	894.96
Comprehensive Income & Other	1,839	170.7	88.52	78.87	78.39	78.39
Shareholders' Equity	1,971	1,874	1,589	1,328	1,219	1,110
Total Liabilities & Equity	2,582	2,171	1,949	1,642	1,642	1,487
Total Debt	98.14	89.41	60.01	-	67.88	64.04
Net Cash (Debt)	680.31	1,390	1,086	470.57	554.06	334.09
Net Cash Growth	-33.49%	27.96%	130.84%	-15.07%	65.84%	-3.86%
Net Cash Per Share	25.30	52.35	41.46	17.96	21.15	12.75
Filing Date Shares Outstanding	26.48	26.44	26.2	26.2	26.2	26.2
Total Common Shares Outstanding	26.48	26.44	26.2	26.2	26.2	26.2
Working Capital	917.95	1,801	1,370	821.09	800.8	617.38
Book Value Per Share	74.42	70.88	60.65	50.68	46.54	42.38
Tangible Book Value	1,077	1,874	1,589	1,327	1,219	1,110
Tangible Book Value Per Share	40.65	70.88	60.65	50.66	46.53	42.37
Land	-	-	87.59	87.59	87.59	87.59
Buildings	-	-	163.8	163.8	160.87	141.83
Machinery	-	20.38	18.02	329.61	328.99	328.55
Construction In Progress	-	-	-	-	-	19.03

Source: S&P Capital IQ. Standard template. Financial Sources.